SEC 13F Intelligence

Frazier Management LLC / AUTL

Frazier Management LLC’s Autolus Therapeutics Ltd Position

Does Frazier Management LLC own Autolus Therapeutics Ltd (AUTL)? Not currently — the last reported position was 3.75M shares worth $19M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$19M
Q4 2021
Shares
3.75M
% of Portfolio
+1.50%
Quarters Held
3
position exited

Position History AUTL

Reported value by quarter
Q2 ’21: $15MQ2 ’21Q3 ’21: $23MQ3 ’21Q4 ’21: $19MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20213.75M$19M+1.50%
Q3 20213.53M$23M+1.85%
Q2 20212.28M$15M+1.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of AUTL.